Further concentration of Haldex CVS' North American manufacturing to the plant in Monterrey, Mexico

Further concentration of Haldex CVS' North American manufacturing to the
plant in Monterrey, Mexico

As a final step in the earlier announced Cost-Reduction Program, Haldex
conducted a review of Commercial Vehicles Systems' (CVS) production
structure in North America. The review resulted in measures for a
further concentration of CVS' North American manufacturing to the Haldex
plant in Monterrey, Mexico.

The plant is located in a region of increasing significance for the
North American automotive industry and has recently undergone an
investment program.

Within the framework of the review, manufacturing from Haldex's plant in
Iola, Kansas, will be relocated to Monterrey, whereupon the operation in
Iola will be discontinued during the second half of 2010. The production
of brake cylinders was relocated to the operation in Monterrey earlier.

Costs for the planned measures will amount to USD 5.6 m (about SEK 45 m)
and will generate annual savings of USD 6 m (about SEK 50 m).

In addition, personnel cutbacks are planned for certain areas of CVS's
operations, the costs for which are expected to amount to SEK 10-15 m,
and will generate annual savings of approximately the same amount.

The costs will be charged to earnings in the third quarter of 2010.

For additional information, please contact:

Joakim Olsson, President and Group CEO, phone +46 8 545 049 52 or Stefan
Johansson, CFO, phone +46 8 545 049 51.